Published in Br J Clin Pharmacol on May 01, 2014
Omitted doses as an unintended consequence of a hospital restricted antibacterial system: a retrospective observational study. J Antimicrob Chemother (2015) 0.75
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59
A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol (2005) 5.26
Risk factors for Clostridium difficile infection. J Hosp Infect (1998) 3.81
Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07
Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect (1996) 2.34
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis (2001) 1.92
Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother (2012) 1.86
Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis (2003) 1.76
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother (2007) 1.72
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother (2003) 1.64
Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother (2008) 1.60
Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol (2008) 1.48
Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol (2009) 1.48
Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother (2011) 1.39
A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med (2006) 1.34
Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents (2000) 1.33
Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother (2009) 1.22
Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect (2001) 1.15
Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect (2009) 1.12
Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis (2006) 1.11
Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study. Infect Control Hosp Epidemiol (2005) 1.11
Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. J Hosp Infect (2009) 1.05
Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother (2006) 1.04
Carbapenem antibiotics for serious infections. BMJ (2012) 1.04
Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother (2009) 1.01
Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol (2009) 1.01
A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection (2012) 0.97
The role of physical proximity in nosocomial diarrhea. Clin Infect Dis (2000) 0.93
Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital. Int J Antimicrob Agents (2004) 0.92
Antibiotic use and other risk factors at hospital level for outbreaks with Clostridium difficile PCR ribotype 027. J Med Microbiol (2008) 0.90
Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures. Am J Infect Control (2009) 0.83
Clostridium difficile: an update on its epidemiology and role in hospital outbreaks in England and Wales. J Hosp Infect (1999) 0.83
Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf (2009) 3.34
The discomfort caused by patient pressure on the prescribing decisions of hospital prescribers. Res Social Adm Pharm (2010) 1.55
Implementation of a pharmaceutical care service: prescriptionists', pharmacists' and doctors' views. Pharm World Sci (2007) 1.15
Pharmacists' interventions in prescribing errors at hospital discharge: an observational study in the context of an electronic prescribing system in a UK teaching hospital. Drug Saf (2010) 1.12
Exploring the causes of junior doctors' prescribing mistakes: a qualitative study. Br J Clin Pharmacol (2014) 1.12
Uncomfortable prescribing decisions in hospitals: the impact of teamwork. J R Soc Med (2009) 1.08
Risk factors for onset of chronic oro-facial pain--results of the North Cheshire oro-facial pain prospective population study. Pain (2010) 1.06
Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci (2010) 1.05
The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis. Arthritis Rheum (2008) 1.04
Association of functional outcome with both personal- and area-level socioeconomic inequalities in patients with inflammatory polyarthritis. Arthritis Rheum (2009) 1.02
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) (2009) 1.01
Pharmacy users' expectations of pharmacy encounters: a Q-methodological study. Health Expect (2010) 0.95
Receiving a pharmaceutical care service compared to receiving standard pharmacy service in Sweden--How do patients differ with regard to perceptions of medicine use and the pharmacy encounter? Res Social Adm Pharm (2009) 0.88
Exploring subjective outcomes perceived by patients receiving a pharmaceutical care service. Res Social Adm Pharm (2006) 0.88
Did a quality improvement collaborative make stroke care better? A cluster randomized trial. Implement Sci (2014) 0.87
Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis. J Rheumatol (2008) 0.86
Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK Hospitals. Drug Saf (2015) 0.85
Differences in adherence and motivation to HIV therapy--two independent assessments in 1998 and 2002. Pharm World Sci (2006) 0.85
Individual patient's preferences for hypertension management: a Q-methodological approach. Patient Educ Couns (2006) 0.84
Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis. Ann Rheum Dis (2010) 0.83
Shared care arrangements for specialist drugs in the UK: the challenges facing GP adherence. Qual Saf Health Care (2010) 0.82
Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study. Arthritis Res Ther (2011) 0.81
Information in general medical practices: the information processing model. Fam Pract (2009) 0.81
Patients' evaluation of the appropriateness of their hypertension management--a qualitative study. Res Social Adm Pharm (2006) 0.80
A qualitative study of health-care personnel's experience of a satellite pharmacy at a HIV clinic. Pharm World Sci (2005) 0.80
Hospital doctors and their schemas about appropriate prescribing. Med Educ (2005) 0.80
Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system. Value Health (2009) 0.79
The discomfort of an evidence-based prescribing decision. J Eval Clin Pract (2009) 0.79
Injecting drug use in prison: prevalence and implications for needle exchange policy. Int J Prison Health (2015) 0.78
The prescribing of specialist medicines: what factors influence GPs' decision making? Fam Pract (2009) 0.78
Counselling behaviour and content in a pharmaceutical care service in Swedish community pharmacies. Pharm World Sci (2010) 0.78
Cardiovascular risk in inflammatory rheumatic diseases: loose ends and common threads. J Rheumatol (2006) 0.77
Satisfaction predictors and attitudes towards electronic prescribing systems in three UK hospitals. Pharm World Sci (2010) 0.77
Validating reasons for medication discontinuation in electronic patient records at hospital discharge. J Eval Clin Pract (2011) 0.75
Comparing costs of home- versus hospital-based treatment of infections in adults in a specialist cystic fibrosis center. Int J Technol Assess Health Care (2005) 0.75